ArticleCureus2026
Risk Factors and Clinical Outcomes of Glucose-6-Phosphate Dehydrogenase Deficiency in Neonates: A Case-Control Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common inherited enzymatic disorder and a major risk factor for neonatal hyperbilirubinemia. This study aims to identify baseline risk factors and evaluate clinical outcomes associated with G6PD deficiency in neonates. Methods A case-control study was conducted, including 150 neonates, comprising 50 G6PD-deficient cases and 100 controls. Demographic characteristics, clinical variables, and laboratory parameters were compared between groups. Categorical variables were analyzed using chi-square (χ²) tests, and continuous variables were analyzed using the Mann-Whitney U test. A p-value <0.05 was considered statistically significant. Results Significant associations were observed between G6PD deficiency and male sex, ethnicity, family history of G6PD deficiency, prolonged hospital stay, phototherapy requirement, and presence of jaundice (p <0.001). G6PD-deficient neonates had significantly higher total bilirubin levels and lower G6PD enzyme levels compared with controls. No significant associations were found with gestational age, feeding type, mode of delivery, or maternal and fetal complications. Conclusions G6PD deficiency was significantly associated with key risk factors like male gender, ethnicity, family history of G6PD, and clinical outcomes, including neonatal hyperbilirubinemia, jaundice, prolonged hospitalization, and increased phototherapy requirement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.